Condition: End-Stage Kidney Disease · Sponsor: University of Sydney
This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.
This description comes directly from the study's public registry record.
Grace Balicki · grace.balicki@sydney.edu.au
Erika Dempsey · erika.dempsey@sydney.edu.au
Always discuss trial participation with your own doctor first.
| Royal Adelaide Hospital | Adelaide, Australia | Recruiting |
| Auburn Hospital | Auburn, Australia | Recruiting |
| Flinders Medical Centre | Bedford Park, Australia | Recruiting |
| Moorabbin Hospital | Bentleigh East, Australia | Recruiting |
| Sunshine Coast University Private Hospital | Birtinya, Australia | Recruiting |
| Princess Alexandra Hospital | Brisbane, Australia | Recruiting |
| Redlands Hospital | Brisbane, Australia | Recruiting |
| Bundaberg Hospital | Bundaberg, Australia | Recruiting |
| Caloundra Hospital | Caloundra, Australia | Recruiting |
| Royal Prince Alfred Hospital | Camperdown, Australia | Recruiting |
| The Canberra Hospital | Canberra, Australia | Recruiting |
| Peninsula Health | Frankston, Australia | Recruiting |
+ 252 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02823821